Izlaganje sa skupa
The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC)
J Gardašanić
M Štefanić
I Mihaljević
B Krstonošić
Puni tekst: hrvatski pdf 497 Kb
str. 114-114
preuzimanja: 388
citiraj
APA 6th Edition
Gardašanić, J., Štefanić, M., Mihaljević, I. i Krstonošić, B. (2007). The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC). Acta clinica Croatica, 46 (3-Supplement 2), 114-114. Preuzeto s https://hrcak.srce.hr/17577
MLA 8th Edition
Gardašanić, J, et al. "The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC)." Acta clinica Croatica, vol. 46, br. 3-Supplement 2, 2007, str. 114-114. https://hrcak.srce.hr/17577. Citirano 19.04.2024.
Chicago 17th Edition
Gardašanić, J, M Štefanić, I Mihaljević i B Krstonošić. "The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC)." Acta clinica Croatica 46, br. 3-Supplement 2 (2007): 114-114. https://hrcak.srce.hr/17577
Harvard
Gardašanić, J., et al. (2007). 'The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC)', Acta clinica Croatica, 46(3-Supplement 2), str. 114-114. Preuzeto s: https://hrcak.srce.hr/17577 (Datum pristupa: 19.04.2024.)
Vancouver
Gardašanić J, Štefanić M, Mihaljević I, Krstonošić B. The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC). Acta clinica Croatica [Internet]. 2007 [pristupljeno 19.04.2024.];46(3-Supplement 2):114-114. Dostupno na: https://hrcak.srce.hr/17577
IEEE
J. Gardašanić, M. Štefanić, I. Mihaljević i B. Krstonošić, "The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC)", Acta clinica Croatica, vol.46, br. 3-Supplement 2, str. 114-114, 2007. [Online]. Dostupno na: https://hrcak.srce.hr/17577. [Citirano: 19.04.2024.]
Puni tekst: engleski pdf 497 Kb
str. 114-114
preuzimanja: 287
citiraj
APA 6th Edition
Gardašanić, J., Štefanić, M., Mihaljević, I. i Krstonošić, B. (2007). The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC). Acta clinica Croatica, 46 (3-Supplement 2), 114-114. Preuzeto s https://hrcak.srce.hr/17577
MLA 8th Edition
Gardašanić, J, et al. "The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC)." Acta clinica Croatica, vol. 46, br. 3-Supplement 2, 2007, str. 114-114. https://hrcak.srce.hr/17577. Citirano 19.04.2024.
Chicago 17th Edition
Gardašanić, J, M Štefanić, I Mihaljević i B Krstonošić. "The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC)." Acta clinica Croatica 46, br. 3-Supplement 2 (2007): 114-114. https://hrcak.srce.hr/17577
Harvard
Gardašanić, J., et al. (2007). 'The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC)', Acta clinica Croatica, 46(3-Supplement 2), str. 114-114. Preuzeto s: https://hrcak.srce.hr/17577 (Datum pristupa: 19.04.2024.)
Vancouver
Gardašanić J, Štefanić M, Mihaljević I, Krstonošić B. The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC). Acta clinica Croatica [Internet]. 2007 [pristupljeno 19.04.2024.];46(3-Supplement 2):114-114. Dostupno na: https://hrcak.srce.hr/17577
IEEE
J. Gardašanić, M. Štefanić, I. Mihaljević i B. Krstonošić, "The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC)", Acta clinica Croatica, vol.46, br. 3-Supplement 2, str. 114-114, 2007. [Online]. Dostupno na: https://hrcak.srce.hr/17577. [Citirano: 19.04.2024.]
Sažetak
Ključne riječi
Hrčak ID:
17577
URI
https://hrcak.srce.hr/17577
Datum izdavanja:
1.10.2007.
Podaci na drugim jezicima:
hrvatski
Posjeta: 1.333
*
